Antibody-Drug Conjugates Targeting the EGFR Ligand Epiregulin Elicit Robust Anti-Tumor Activity in Colorectal Cancer.
Jacob J, Anami Y, High PC, Liang Z, Subramanian S, Ghosh SC, AghaAmiri S, Guernsey-Biddle C, Tran H, Rowe J, Azhdarinia A, Tsuchikama K, Carmon KS.
Jacob J, et al. Among authors: subramanian s.
Cancer Res. 2024 Dec 18. doi: 10.1158/0008-5472.CAN-24-0798. Online ahead of print.
Cancer Res. 2024.
PMID: 39693606